See every side of every news story
Published loading...Updated

New Analytics ID Metabolite Variations Tied to CHO Cell Efficiency

Summary by GEN - Genetic Engineering and Biotechnology News…
Chinese hamster ovary (CHO) cells were the protein production platform used in 89% of the biologics drugs approved between 2018 and 2022, and their use does not appear to be slowing. Manufacturers are turning to continuous cell culturing to meet demands, but that alone cannot create enough product to meet customer needs. Protein production using CHO cells, therefore, must become even more efficient. “Optimizing not only viable cell density but a…

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GEN - Genetic Engineering and Biotechnology News… broke the news in on Wednesday, March 26, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.